Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceutical products in India and internationally. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.
Research context
Balaxi Pharmaceuticals Limited appears in PyInvesting’s India Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- INR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Balaxi Pharmaceuticals Limited is currently in a long term downtrend where the price is trading 6.5% below its 200 day moving average.
From a valuation standpoint, the stock is 5.1% cheaper than other stocks from the Other sector with a price to sales ratio of 2.2.
Balaxi Pharmaceuticals Limited's total revenue rose by 402.1% to $660M since the same quarter in the previous year.
Its net income has increased by 343.0% to $110M since the same quarter in the previous year.
Finally, its free cash flow grew by 120.3% to $17M since the same quarter in the previous year.
Based on the above factors, Balaxi Pharmaceuticals Limited gets an overall score of 4/5.